Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Gastritis 2Stomach Ulcer 1Peptic Ulcer 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Dyspepsia 1

Interventions

Cisplatin 117Oxaliplatin 111Fluorouracil 100Capecitabine 90Docetaxel 69Leucovorin 60Irinotecan 57Paclitaxel 49S 1 (combination) 38pembrolizumab 33Trastuzumab 31Radiotherapy 25Bevacizumab 20Nivolumab 19Epirubicin 19titanium silicide 18Surgical Procedures, Operative 17Carboplatin 17Ramucirumab 15Cetuximab 15Gastrectomy 13apatinib 12Everolimus 12Gemcitabine 11Albumin-Bound Paclitaxel 10Neoadjuvant Therapy 8Folfox protocol 8Drug Therapy 8Chemotherapy, Adjuvant 8Radiation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Stomach Neoplasms × Furazolidone × Clear all
NCT04678492 2023-01-31

Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed
658 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

NCT03609892 2019-08-30

Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed
658 enrolled
Gastrointestinal

Gastritis, Stomach Neoplasms, Stomach Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡